» China Shuts Down Leukemia Drug Maker
» Japan Scientists Develop Fearless Mouse
» New Voices a Monthly Feature Porviding a Forum for Area Youths to Express Thier Ideas
» Stanford Scientists Awarded $10.7 Million in Latest State Stem Cell Grants
» Boomers Need to Plan for Their Parents' Long-Term Care
» Area Libraries Announce Program Schedule for December
» Witch's Hat Much Less Wicked
» Club & Organization Activities
» Diabetes Drug Poses Risk for Elderly
» Merck Recalls 1M Childhood Vaccines
» Woman Misdiagnosed With HIV Gets $2.5 M
» Families Flee Freezing, Powerless Homes
» US Cholesterol Average Is Ideal at 199
» Neupro(R) Filed With the FDA for the Treatment of Restless Legs Syndrome
» Neupro(R) Filed With the FDA for the Treatment of Advanced-Stage Parkinson's Disease
» Sensible Diet Key to Health
» ZymoGenetics and Merck Serono Initiate Phase 2/3 Clinical Trial of Atacicept in Lupus Nephritis
» Nurse in Chester Maggot-Wound Case is Sentenced
» Morning-After Drug Bill Advances
» Progress Cited in Fighting Dystrophy
» Seniors Face High-Pressure Sales Tactics on Medicare Insurance: Deceptive Agents Push Inappropriate Medicare Plans to the Elderly
» GTC's ATryn Receives FDA Orphan Designation
» Misys Healthcare's Leading Solutions Deliver Results for More and More Customers
» ZymoGenetics Presents Positive Results for Interleukin Combination Drug
» FDA Panel Recommends Kynapid Approval for Atrial Fibrillation
» Neurocrine Receives Approvable Letter for Indiplon Capsules With Additional Safety and Efficacy Data Required By FDA
» Gene Linked to Aggressive Prostate Cancer
» Chroma Announces Positive Phase I Efficacy Data for Novel Cancer Therapy CHR-2797
» Merck Wants Mevacor Sold Over-Counter
» Lawsuits Allege Milk Wasn't Organic
» 'Sweat is Not the Answer'
» Reflux Among Babies Often a Misdiagnosis
» Maximizing the Contribution of the Public Health Workforce
» Heart Disease Can Help Surgery
» The Health and Science of Starting Sex
» The State of the International Organ Trade
» Former Philadelphia Eagle Mike Quick Joins American Lung Association
» PETA Targets Homeland Security Tests
» U.S. Preventive Medicine to Expand into England With iHealth UK Ltd.
» Public Health Schools: Six Portraits
» How Brazil Turned One Public Health School into 40
» FDA Accepts EntreMed's IND for Panzem
» Models of Public Health Education: Choices for the Future?
» Shaping Public Health Education Around the World to Address Health Challenges in the Coming Decades
» A Solution for Creating Competent Health-Care Specialists: the Swiss School of Public Health+
» Factors Affecting Nurse Prescribing
» Problems and Progress in Public Health Education
» All for One, One for All
» Regional Public Health Education: Current Situation and Challenges
» Mapping Africa's Advanced Public Health Education Capacity: the AfriHealth Project
» Training of Public Health Workforce at the National School of Public Health: Meeting Africa's Needs
» Needs and Numbers Are Health Visiting Priorities
» Building Leadership for Health
» Global Health Diplomacy: Training Across Disciplines
» Strategic Policy Issues and Music Teacher Preparation
» Generex Receives Approval for Oral-Lyn in UAE
» Hospital Ready to Grow: Marshall Sees Spring Start to Project, With State OK.
» LGH Wins Federal Health/Safety Award
» License of Prairie Village Day Care Suspended After Molestation Allegation
» Papua New Guinea Man Sentenced to Death for Child Murder
» Atrium ER Will Open Today in Middletown
» Men's Health - The Practice Nurse's Handbook
» Same Day Brain Tumour Ops
» Current Concerns in Transplantation
» International Perspectives on the Ethics and Regulation of Human Cell and Tissue Transplantation
» New Online Learning Tool Fills the Knowledge Gap on Botulinum Toxin Type B for Cervical Dystonia
» Peake Pledges Better Mental Health Care
» Puricase(R) (Pegloticase) Meets Pre-Specified Primary Efficacy Endpoint in Two Replicate Phase 3 Studies
» American Specialty Health Successfully Renews NCQA 'Organizational Certification' in Credentialing and Utilization Management
» Gene Logic Shareholders Approve Assets Sale and Name Change
» Court Grants Depomed's Motion for Summary Judgment of Patent Infringement Against IVAX
» Orexigen Starts Phase III Obesity Trial for Contrave
» Moores Cancer Center Initiates Phase III Study of Melanoma Drug
» Curidium Medica - Presentation at Showcase
» Space-tech Could Make Life Easier for Diabetics
» Antibodies Against Synthetic Deamidated Gliadin Peptides As Predictors of Celiac Disease
» More Indian Mothers Getting Prenatal Care
» Blood Clinics on Their Way Back
» Stanford Hauls in Stem-Cell Money
» New Scanners 'Urgently Needed'
» Is This Year For Reform? After Haven Healthcare Scandal, Legislators Sense Time To Act Is Near
» New Year's Eve Events in Roanoke, Blacksburg and Beyond
» Papua New Guinea: A Warmer World Raises Malaria to New Heights
» Arena Pharmaceuticals Initiates Second and Third Pivotal Trials Evaluating Lorcaserin for the Treatment of Obesity
» Researchers Find Smoking Raises Risk of Diabetes
» Americans Don't Make the Grade When It Comes to the ABCs of Nutrition and Multivitamins
» IsoRay's Cesium-131 Medical Isotope Used in Milestone Procedure Treating Eye Cancers at Tufts-New England Medical Center
» GlaxoSmithKline Presents Innovative Neuroscience Pipeline
» Over-The-Counter Cholesterol Drug Sought
» Cholesterol Levels Attain Milestone: Drugs Credited With Helping; Merck Seeks Over-the-Counter OK
» Genmab Initiates Ofatumumab Phase II Study in Diffuse Large B-Cell Lymphoma
» Creating a Culture of Health By Engaging the C Suite and Employees to Promote Better Health Webinar on CD ROM is Out Now
» Novelos Therapeutics Concludes Nov-205 Hepatitis C Trial Based on Favorable Safety Profile
» Idera Pharmaceuticals Initiates Phase 1b Trial of IMO-2055 in Combination With Targeted Agents in Non-Small Cell Lung Cancer
» AMAG Pharmaceuticals, Inc. Announces Update on Sinerem(TM) in Europe
» Genmab Announces Details of Planned Ofatumumab Phase II Study in Multiple Sclerosis
» Hypothermia Prompts Some to Undress
» Rigel's R788 Demonstrates Significant Improvement in Rheumatoid Arthritis in Phase 2 Clinical Study
» EMD Serono Announces Support of The Michael J. Fox Foundation for Parkinson's Research
» Analytical Validation and Biological Evaluation of a High-Molecular- Weight Adiponectin ELISA
» Facility May Give Abusers Forced Detox
» Sunny Sounds to Cheer Patients
» Pharmacies to Offer Women Pill Without a Prescription
» Boca Raton Heart Institute Tallies 270 Surgeries in First 15 Months: More Than 270 Open-Heart Surgeries Done at Boca Hospital
» AMERIGROUP Foundation Awards $100,000 to Grady Health System Foundation in Atlanta
» Bethesda Memorial Hospital Receives $2.7 Million Gift to Open the Walter S. And Lucienne Driskill Endovascular Center
» Bug Closes Wards to Admissions
» Lake County's Free Clinic Rehabs Mundelein Site to Reach More Patients
» New Move to Tackle Abuse of Alcohol
» Modified Human Stem Cells Rescue Diseased Muscle in Mice
» Authorities Net 300 Lbs. Of Pot in Bust
» Hundreds Pray for Lexi at Vigil
» DuoCort Ends Enrollment for Adrenal Insufficiency Trial
» Request an Explanation for Doctor's Bill
» Naviscan's PEM Flex(TM) Scanner Shows Promising New Data in Breast Cancer Management
» Empty Stocking Fund Agency Profile: Fort Mill Care Center
» Hospital's New Quiet Place for All Faiths
» Holiday Season Brings $150,500 in Scholarships for Southern California Nursing Students
» Landmark Contribution Boosts Homeless Effort
» Outdoor: Calendar
» Reading Eagle, Pa., Community Bulletin Board Column: Holiday Highlights
» Bond Proposal Could Fund Medical School: Governor Will Outline Statewide Initiative Today.
» First Day at School for Heart-Battle Youngster
» Regents OK List of Architects: OU Will Whittle the List for the Design of a Clinic in North Tulsa.
» Questions Linger In Girl's Death
» Croatian War Crimes Suspect Transferred to Prison Hospital
» Stubbing Out Smoking at Hospitals
» Healthcare Trends & Forecasts in 2008: Report Available Now
» MicroIslet Holds Positive Pre-IND Meeting for US Based Human Clinical Trial With FDA
» DiaMedica Receives Regulatory Clearance for Phase II Human Study of DM-83
» Most Hospital Pharmacy and Therapeutics Committee Members Anticipate That Drugs From Johnson & Johnson/Basilea and Theravance/Astellas Will Achieve Formulary Inclusion Among Hospitals but With Restrictions
» Dr. Maurizio Zanetti Joins InNexus Biotechnology Scientific Advisory Board
» SemBioSys Appoints Former Esperion Officer to Board of Directors
» Sinovac's Hepatitis A Vaccine Healive Selected By Beijing Centers For Diseases Control and Prevention
» Purdue Center Takes on North American Battle Against Multidrug-Resistant Tuberculosis
» Canada's Leading Cardiovascular Center Uses Affymetrix SNP Array 6.0 to Replicate Whole-Genome Association Study Findings
» Alnylam Reports Continued Progress in Clinical Development of ALN-RSV01 for the Treatment of Respiratory Syncytial Virus (RSV) Infection
» Neurologix Gene Therapy Approach to Parkinson's Disease Granted Fast Track Designation From FDA
» CoNCERT Pharmaceuticals Strengthens Executive Leadership Team
» Genimmune's Hepatitis C Antibody Granted European Orphan Designation
» New Clinical Data Shows Chromium Picolinate Improves Cognitive Function
» Genzyme Study of Myozyme(R) for Late-Onset Pompe Patients Meets Co-Primary Efficacy Endpoints
» KSW Selected As Trade Manager on Mt. Sinai Hospital Project
» VeinViewer By Luminetx(TM) Receives Key Quality and European Certifications
» Rosetta Genomics and Columbia University Medical Center to Develop MicroRNA-Based Diagnostics for Leukemia and Non Hodgkin Lymphoma
» Phase II Study of IMC-1121B for Advanced Malignant Melanoma Commences Patient Enrollment
» Inova Health System Awards Contract to Sysmex America for Enterprise-Wide Integrated Hematology Systems
» 'Delivering Disease Management to Medically Underserved Populations' Report Will Help You Begin Implementing Program Success With Community Agency and Provider Partnerships
» Health Net, Inc. Fourth Quarter and Year-End 2007 Earnings Conference Call
» Artes Medical's ArteFill Selected As Finalist for San Diego's Connect ''Most Innovative New Product'' Award
» Sinovac Requests Extension for Annual Shareholders Meeting
» Novartis to Cut 2,500 Jobs by 2010
» Independent Research Group Reports That Pressure BioSciences' Award Winning ProteoSolve-LRS Technology Played a Significant Role in the Identification of Potential Biomarkers in Breast and Colon Cancer Tissue
» Copernicus Receives Milestone Payment From CFFT
» Study Says Fewer Lack Food, Health Care
» When Pickles Are Your Life's Calling
» Hospital Bed Delay Causes Domino Effect
» Chroma's Leukemia Drug Meets Phase I Goals
» ZoomCare Expands Health Care on Demand(TM) Team and Attracts Top Talent
» 31 Million Americans Suffer From Sinus Infections
» Theravance Says GSK Has Initiated Phase I Study for COPD Drug
» PARI's eFlow Delivers Alnylam RNAi Therapeutic in Phase I Study
» Dr. Christine Cauffield Named Co-Chair of Florida Agency Devoted to Improving Mental Health Services for Seniors
» Netsmart Technologies Announces Availability of Video Case Studies for Behavioral and Public Health
» Parkinson's Raises Risk of Depression in Family
» Rigel's Rheumatoid Arthritis Drug Effective in Phase II Study
» Taxotere(R)-Based Chemotherapy Significantly Improved Overall Survival Compared With Standard Anthracycline-Based Chemotherapy in Early Stage Breast Cancer
» Pharming Prepares to Appeal Ruling on European Marketing Authorization Application for Rhucin(R)
» Sirtris Pharmaceuticals' SIRT1 Activator Controls Glucose As Well As a DPP-4 Inhibitor in a Pre-Clinical Model of Type 2 Diabetes
» Senators Urge Drug Access: Pre-Approving Mental-Health Medication a Bad Idea, Governor is Told
» Delta Health to Discontinue Family Planning Services in Lodi: Medi-Cal Clients Left With Just One Provider for Similar Care
» Using Mind to Mend: Trauma Victims Trying Meditation in Efforts to Heal
» What to Do If You Fall Ill This Winter
» Dublin Cancer Center Revived: Cleveland Clinic May Run Particle-Therapy Project
» Abuse Doctor Sacked
» Online Help for Caregivers
» Boy With Growth to Be Treated in Boston After Being Turned Down in Toronto
» CSI's VP Buettner Set to Retire Jan. 25
» CDC Uses New Technical Approach to Enable Hospital Reporting of Healthcare-Associated Infections
» CBS to Air Show About Castro Valley 'Jane Doe'
» Senate Panel OKs Peake Nomination to VA
» MHA Announces Release of RxPertise 7.0 Release 2
» Insmed Awarded $2.1 Million Grant By MDA
» Walgreens First Quarter Earnings Release, Conference Call on Dec. 21
» Building Reserves to Keep the Brain Fit
» Doctors and Dentists Account for 27 Percent of $1.6 Trillion in Health Care Revenue
» Consorta Launches EverGreen Magazine to Spotlight Green Procurement and Sustainable Environmental Practices
» VGX Suspends HCV Drug Development Program
» Merck Recalls Children's Vaccine
» Hemispherx Biopharma Announces Licensing/Research Agreements On Ampligen As Influenza Adjuvant With Japan's BIKEN; Facilitates Bird Flu Vaccine Development Funded By Japanese Government
» Applied NeuroSolutions Appoints Ellen R. Hoffing to Additional Role As Chairman of the Board of Directors
» Partners in Pediatrics Introduces Naturally Healthy Kids, a Reference Book for Illness and Wellness in Children Now Available Nationwide
» Research and Markets: Desktop Management Investment in Healthcare H2 2006 (Databook)
» ImClone Starts Enrollment in Phase II Melanoma Trial
» Vanda Finds Iloperidone Effective Against Schizophrenia
» California Drug and Alcohol Clinic Becomes the First in the Nation to Offer DNA-Customized Treatment for Individuals With a Genetic Predisposition for Addictive Behavior
» New Report: Tobacco Regulation Would Save Iowa $449 Million in Health Care Costs By Preventing 25,700 Kids From Smoking
» Childhood Cancer Survivors Catch Up
» Natus Medical to Release 2008 Financial Guidance on December 18
» BioTime Forms New Subsidiary
» Green Tea May Help Fight Parkinson's
» Fitness Guru Offers Novel Exercise Program and Tips to Stick With Exercise in the New Year
» EDAP Announces First Published Long-Term Study of HIFU for Localized Prostate Cancer
» Alzheimer's Diagnosis Doesn't Stop Man From Enjoying His Life
» BioMarin Announces FDA Approval for Kuvan
» UCB Files sNDA for CNS Drug
» Oral Health America's Robert Klaus Honored for Outstanding Public Advocacy
» Health Woes
» VA Urged to Head Off Potential Rash of Suicides
» Supermarkets to Give Health Checks
» Stop Smoking in Hospital Grounds
» Elective Cesareans Up Breathing Problems
» Another City Hospital Ward Shut As Bug Toll Rises to 109 Admissions Halted As Patients, Staff Suffer Vomiting
» Sportsmen Link to Gilgen Steroids Case
» Catholic Health Groups Won't Offer Abortions
» NDO's Surgical Device Found Effective Against GERD
» Rheumatism Seminar Educates Patients
» DHB Needs to Quit Its Bunker
» One-Woman Snack Company
» Police Still to Speak to Students
» FDA to Review ProEthic's Migraine Drug
» Commonwealth of Pennsylvania Emergency Operations Center and Joint Information Center Activated for Winter Storm Response
» PCI Guideline Update Stresses Long-Term Anticoagulant Therapy After Treatment With Drug-Eluting Stents
» Cleveland BioLabs Recaps Development of Lead Compounds and Affirms Confidence in Competitive Position for Department of Defense Contract
» Iloperidone Phase III Clinical Data Demonstrate Efficacy and Favorable Safety and Tolerability Profile
» Wyeth Reports Positive Pristiq Data
» Teva Gets Approval for Generic Epilepsy Drug
» Swedish Agency Approves NsGene for Alzheimer's Drug Trial
» Neurologix's Gene Procedure Receives Fast Track Designation
» US Veterans Affairs Hospitals Select Picis CareSuite
» Ceregene's Drug Shows Reduction in Parkinson's Symptoms
» Nuvelo's Stroke Drug Enters Phase II Trial, Gets Fast Track Status
» Solvay Responds to FDA Panel Recommendation
» ValueOptions(R) and Crestview Partners Close Transaction
» Geron Receives Milestone Payment From Merck
» Allarae Healthcare Inc. Announces Signing of Distribution Agreement With Intellect Inc.
» J&J Says Invega Shows Favorable Safety Profile in Schizophrenia
» Merck Initiates Phase II/III Clinical Trial of SLE
» FDA Panel Rejects OTC Cholesterol Drug
» Fewer Breast Patients May Need Chemo
» New Contraception Procedure Recommended
» This 12-Year-Old Girl Was Given a Morning After Pill at Boots
» One Thing Washington Can Agree On: Time for E-Prescribing in Medicare
» FDA Advisory Panel Recommends Against Approval of Merck's NDA for Non-Prescription MEVACOR(R) (Lovastatin) 20 Mg
» FDA Advisers Say No to Merck Drug Bid
» Priority Health Offers More Choice With Addition of Physicians and Health Care Centers to Southeast Michigan Network
» Solihull News: Have Your Say on Future of Local Health Services ; SOLIHULL
» Gym Gets a Revamp
» Padded Bill an Rx for Fraud
» Diet Pills Doctor is Suspended for a Year
» Strategies for Fighting Colds
» Art Scene - Artists From Israel, Russia and Cranston Make a Splash
» It's Time to Get Real (Well Virtual, Anyway) ; AGENDA
» Healthy Dose HRT Lesson is to Be More Vocal, Decisive With Our Doctors
» Nadey Hakim
» EDITORIAL ; SJC Goes Astray on Doctor's Duty
» Vomiting Bug Spreads
» YMCA to Build a Second New Facility Downtown
» Chemists to Hand Out Pill
» Kilfoyle Health Bill Warning
» Praise for Cancer Drive
» Katys Death is Tip of the Iceberg
» Bay Area Sutter Nurses Walk Off Jobs
» Doctors in Shops Bid
» Novant to Build Surgery Center
» My Southside Notebook Musical Storytime for Kids is at Borders
» Edward Hospital Statement Regarding Indictment of P. Nicholas Hurtgen
» Cost-Cutting Idea - New Agency Proposed
» The Stirrer: Targets Vs Lives, Says Union
» Murray Doc Charged in Drug Scam
» With Cold Medicines Gone, Parent Seek Options for Sick Kids
» Hula Hoops Fight Childhood Obesity
» Chronic Disease Affects Nine Million Canadians, Survey Finds
» Health Coverage for Poor Pitched
» InfoLogix CEO Scheduled to Discuss Medication Management Issues Live on FOX Business News, Friday, December 14 at 9:40 A.M.
» Embla Systems in Collaboration With Beth Israel Deaconess Medical Center to Develop Cardio-Pulmonary Coupling Technology
» American Heart Association/American College of Cardiology/Society for Cardiovascular Angiography and Interventions Joint Scientific Statement
» MammaPrint(R) Breast Cancer Test Validated in Lymph Node-Positive Breast Cancer Patients
» BD Acquires Right to Negotiate Business Relationship for Accelr8's BACcel(R) Rapid Diagnostics Technology
» Medicare Fraud Strike Force Cases Result in Long Prison Terms for Five Health Care Company Owners
» HealthTeacher and Alignment Nashville Team To Provide Health Education to 75,000 Students
» Use of Opiate Drug Replacement Therapies on the Rise in the United States
» Boston Scientific Agrees To Sell Fluid Management and Venous Access Businesses to Avista Capital Partners for $425 Million
» QRxPharma Initiates Second Phase III Clinical Trial for Its 'Dual Opioid' Pain Therapy
» Democratic Debate Quotes
» eBenefits Direct Subsidiary, L.A. Marketing Plans, Launches Call Center in Portland, Maine, to Market Healthcare Programs to Uninsured Individuals Across the U.S.
» Alphatec Holdings, Inc. Announces Revenue Guidance for Fiscal Year 2008
» FDA Panel Nixes Over-the-Counter Cholesterol Drug
» Study: Gene Test Can Determine Who Benefits From Chemotherapy
» Tips Given to Avoid Pregnancy Heartburn
» RLF Nursing Home is Up for Sale
» McKenna Calls for Stricter Law to Keep Guns From Mentally Ill
» Canada's Radioisotope Reactor to Restart
» Stem Cell Research First
» UND Medical School Receives $5 Million Gift From Alumna
» Terry Pratchett Diagnosed With Alzheimer's
» Shingles Also Prevalent Among Healthy
» FDA Advisory Panel Finds Hologic's Adiana(R) Permanent Contraception Approvable